Science Explorer Back to mapMap
Discussion
Company · Cambridge · United Kingdom

Gilead Sciences (United Kingdom)

gilead.co.ukROR OpenAlex
Research works
114
▲ 110% vs 2018-21
Citations
1.3k
11.3 per fractional work
Top-10% rate
9.4%
all institutions 10.0%
Open access
55%
world 40%
International
69%
world 18%
Gilead Sciences (United Kingdom)

Not ranked overall: Gilead Sciences (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Gilead Sciences (United Kingdom) work in?

In 2022-now, 64% of research at Gilead Sciences (United Kingdom) is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (61%), Biochemistry, Genetics and Molecular Biology (7%), Economics, Econometrics and Finance (7%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 39 fractional works · 64.1% of its workMedicine: 37 fractional works · 61.2% of its workOncology: 8 fractional works · 13.9% of its workInfectious Diseases: 5 fractional works · 8.1% of its workPulmonary and Respiratory Medicine: 4 fractional works · 6.4% of its workEpidemiology: 4 fractional works · 6.1% of its workHepatology: 3 fractional works · 4.7% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 2.7% of its workEmergency Medicine: 1 fractional works · 2.4% of its workPathology and Forensic Medicine: 1 fractional works · 2.2% of its workPhysiology: 1 fractional works · 2.0% of its workHematology: 1 fractional works · 1.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.4% of its workSurgery: 1 fractional works · 1.4% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.1% of its workNeurology: 0 fractional works · 0.8% of its workDermatology: 0 fractional works · 0.8% of its workGeriatrics and Gerontology: 0 fractional works · 0.8% of its workRheumatology: 0 fractional works · 0.7% of its workGenetics: 0 fractional works · 0.7% of its workFamily Practice: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workGastroenterology: 0 fractional works · 0.3% of its workHealth Informatics: 0 fractional works · 0.3% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workPharmacology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workHealth Professions: 2 fractional works · 2.7% of its workGeneral Health Professions: 1 fractional works · 2.0% of its workHealth Information Management: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.0% of its workLife Sciences: 10 fractional works · 17.2% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 6.9% of its workMolecular Biology: 2 fractional works · 3.4% of its workCancer Research: 1 fractional works · 2.0% of its workGenetics: 1 fractional works · 1.0% of its workBiochemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 4 fractional works · 6.4% of its workImmunology: 3 fractional works · 4.3% of its workVirology: 1 fractional works · 1.4% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.4% of its workMicrobiology: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 2.9% of its workPharmaceutical Science: 1 fractional works · 1.1% of its workPharmacology: 1 fractional works · 1.0% of its workToxicology: 0 fractional works · 0.8% of its workNeuroscience: 0 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workSocial Sciences: 7 fractional works · 12.4% of its workEconomics, Econometrics and Finance: 4 fractional works · 6.6% of its workEconomics and Econometrics: 3 fractional works · 4.9% of its workFinance: 1 fractional works · 1.7% of its workSocial Sciences: 1 fractional works · 1.9% of its workSociology and Political Science: 1 fractional works · 1.3% of its workEducation: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPsychology: 1 fractional works · 1.8% of its workSocial Psychology: 1 fractional works · 1.0% of its workClinical Psychology: 0 fractional works · 0.4% of its workApplied Psychology: 0 fractional works · 0.4% of its workDecision Sciences: 1 fractional works · 1.3% of its workManagement Science and Operations Research: 0 fractional works · 0.7% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.8% of its workStrategy and Management: 0 fractional works · 0.8% of its workPhysical Sciences: 4 fractional works · 6.3% of its workComputer Science: 3 fractional works · 4.5% of its workComputer Networks and Communications: 2 fractional works · 3.0% of its workArtificial Intelligence: 0 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.4% of its workInformation Systems: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.6% of its workStatistics and Probability: 0 fractional works · 0.6% of its workEngineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.4% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workALL ITS WORKGilead Sciences(United Kingdom)60fractional works, 2022-now
Life Sciences17%Physical Sciences6%Health Sciences64%Social Sciences12%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine3761.2%
    2. Health Professions22.7%
    3. Veterinary00.2%
    4. Nursing00.0%
    1. Biochemistry, Genetics and Molecular Biology46.9%
    2. Immunology and Microbiology46.4%
    3. Pharmacology, Toxicology and Pharmaceutics22.9%
    4. Neuroscience00.7%
    5. Agricultural and Biological Sciences00.2%
    1. Economics, Econometrics and Finance46.6%
    2. Social Sciences11.9%
    3. Psychology11.8%
    4. Decision Sciences11.3%
    5. Business, Management and Accounting00.8%
    1. Computer Science34.5%
    2. Mathematics00.6%
    3. Engineering00.6%
    4. Environmental Science00.4%
    5. Physics and Astronomy00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.30× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 6.38× its world share, 4 worksImmunology and Micro…Neuroscience: 0.44× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.27× its world share, 2 worksPharmacology, Toxico…Computer Science: 0.58× its world share, 3 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.08× its world share, 0 worksEnvironmental ScienceMathematics: 0.54× its world share, 0 worksMathematicsPhysics and Astronomy: 0.07× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.02× its world share, 2 worksHealth ProfessionsMedicine: 3.18× its world share, 37 worksMedicineNursing: 0.09× its world share, 0 worksNursingVeterinary: 1.27× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.26× its world share, 0 worksBusiness, Management…Decision Sciences: 1.34× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 3.08× its world share, 4 worksEconomics, Econometr…Psychology: 0.59× its world share, 1 worksPsychologySocial Sciences: 0.15× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.3×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics8.27×2 works
  2. Immunology and Microbiology6.38×4 works
  3. Medicine3.18×37 works
  4. Economics, Econometrics and Finance3.08×4 works
  5. Decision Sciences1.34×1 works
  6. Biochemistry, Genetics and Molecular Biology1.30×4 works
  7. Veterinary1.27×0 works
  8. Health Professions1.02×2 works
  9. Psychology0.59×1 works
  10. Computer Science0.58×3 works
  11. Mathematics0.54×0 works
  12. Neuroscience0.44×0 works
  13. Business, Management and Accounting0.26×0 works
  14. Social Sciences0.15×1 works
  15. Nursing0.09×0 works
  16. Environmental Science0.08×0 works
  17. Physics and Astronomy0.07×0 works
  18. Agricultural and Biological Sciences0.05×0 works
  19. Engineering0.04×0 works

Who are the top researchers at Gilead Sciences (United Kingdom)?

Ranked on the quality score, Murad Ruf, Sachin Vadgama and Harriet A. Dickinson lead among researchers whose main affiliation is Gilead Sciences (United Kingdom).

  1. 1 Murad Ruf United Kingdom · #1,732,589 worldwide 919 citations · 37 works
  2. 2 Sachin Vadgama United Kingdom · #1,799,186 worldwide 154 citations · 26 works
  3. 3 Harriet A. Dickinson United Kingdom · #1,898,853 worldwide 529 citations · 28 works
  4. 4 Michael F. Hein United Kingdom · #2,612,355 worldwide 578 citations · 19 works
  5. 5 Marion Milner United Kingdom · #2,715,128 worldwide 656 citations · 40 works
  6. 6 George Stephen United Kingdom · #3,978,742 worldwide 45 citations · 19 works
  7. 7 Rodolphe Perard United Kingdom · #5,049,989 worldwide 164 citations · 26 works
  8. 8 Cándido Hernández United Kingdom · #5,461,465 worldwide 154 citations · 37 works
All ranked researchers at Gilead Sciences (United Kingdom)

What are the most cited papers from Gilead Sciences (United Kingdom)?

The most cited paper from Gilead Sciences (United Kingdom) is "T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma" (Jennifer N. Brudno et al., 2018), with 800 citations. Next come "MAIT cells are activated during human viral infections" (532) and "Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide" (475).

Most cited papers
#PaperReleasedCitations
1 T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma Jennifer N. Brudno et al. · Journal of Clinical Oncology Open access 29 May 2018 800
2 MAIT cells are activated during human viral infections Bonnie van Wilgenburg et al. · Nature Communications Open access 23 Jun 2016 532
3 Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber et al. · Journal of Clinical Oncology Open access 6 Apr 2017 475
4 Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial Kenneth Hugh Mayer et al. · The Lancet Open access Jul 2020 437
5 The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years Mark Richard Nelson, Christine Katlama, Joan Montaner et al. · AIDS Jun 2007 353
All 60 most cited papers, with filters and sorting

Which keywords describe research at Gilead Sciences (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Antiretroviral Therapy, Lymphoma, Immune Response, Immunotherapy, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor and Epidemiology.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology6▲ 2.5×23 topics
  2. Antiretroviral Therapy6▲ 57×5 topics
  3. Lymphoma5▲ 53×2 topics
  4. Immune Response5▲ 15×7 topics
  5. Immunotherapy4▲ 10×5 topics
  6. Cancer Immunotherapy4▲ 47×3 topics
  7. CAR T Cells4▲ 88×1 topic
  8. Chimeric Antigen Receptor4▲ 88×1 topic
  9. Antiviral Therapy3▲ 56×3 topics
  10. HIV Infection3▲ 49×2 topics
  11. Liver Disease3▲ 56×2 topics
  12. Metastatic Breast Cancer3▲ 82×2 topics
  13. Treatment3▲ 3.8×8 topics
  14. Genetic Variation3▲ 20×3 topics
  15. Breast Cancer2▲ 16×3 topics
  16. Hepatitis C Virus2▲ 103×1 topic
  17. Prognostic Factors2▲ 8.0×6 topics
  18. Ribavirin2▲ 103×1 topic
  19. Drug Resistance2▲ 11×2 topics
  20. HIV2▲ 37×3 topics
  21. Insulin Resistance2▲ 7.0×2 topics
  22. Monoclonal Antibodies2▲ 34×3 topics
  23. Mortality Rates2▲ 32×2 topics
  24. Anomaly Detection2▲ 9.6×2 topics
  25. Hepatotoxicity2▲ 59×2 topics
  26. Integrase Inhibitors2▲ 134×1 topic
  27. Nucleoside Analogues2▲ 134×1 topic
  28. Vaccine2▲ 7.2×5 topics
  29. Viral Load2▲ 36×2 topics
  30. Biopharmaceuticals2▲ 50×2 topics
  31. CDK4/6 Inhibitors2▲ 93×1 topic
  32. HIV Transmission2▲ 35×2 topics
  33. Hepatocellular Carcinoma2▲ 13×3 topics
  34. Immunogenicity2▲ 60×2 topics
  35. Palbociclib2▲ 93×1 topic
  36. Preexposure Prophylaxis2▲ 54×1 topic
  37. Rituximab2▲ 18×3 topics
  38. Stigma and Discrimination2▲ 54×1 topic
  39. Neurotoxicity2▲ 21×3 topics
  40. SARS-CoV-22▲ 8.3×3 topics

Which research topics does Gilead Sciences (United Kingdom) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Hepatitis C virus research, HIV/AIDS drug development and treatment and HIV/AIDS Research and Interventions.

CAR-T cell therapy resea…4CAR-T cell therapy research: 4 fractional worksHepatitis C virus research: 2 fractional worksHIV/AIDS drug development and treatment: 2 fractional worksHIV/AIDS Research and Interventions: 2 fractional worksAdvanced Breast Cancer Therapies: 2 fractional worksHIV-related health complications and treatments: 1 fractional worksBiosimilars and Bioanaly…1Biosimilars and Bioanalytical Methods: 1 fractional worksNetwork Security and Intrusion Detection: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksDrug Transport and Resis…1Drug Transport and Resistance Mechanisms: 1 fractional works
OncologyHepatologyInfectious DiseasesPulmonary and Respiratory Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 4 works
  2. 2 Hepatitis C virus research Hepatology 2 works
  3. 3 HIV/AIDS drug development and treatment Infectious Diseases 2 works
  4. 4 HIV/AIDS Research and Interventions Infectious Diseases 2 works
  5. 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  6. 6 HIV-related health complications and treatments Emergency Medicine 1 works
  7. 7 Biosimilars and Bioanalytical Methods Immunology 1 works
  8. 8 Network Security and Intrusion Detection Computer Networks and Communications 1 works
  9. 9 Cancer Treatment and Pharmacology Oncology 1 works
  10. 10 Drug Transport and Resistance Mechanisms Oncology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.6%not open45.4%

World: 40% of research is openly available.

with international co-authors69.4%domestic only30.6%

World: 18% is written across borders.

How has Gilead Sciences (United Kingdom)'s research output changed?

Output in 2022-2025 was 110% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Gilead Sciences (United Kingdom) as a percentage of every work published that year, 0.00026% in 2024.

still counting0.00010%0.00020%0.00030%Gilead Sciences (United Kingdom)0.00028% in 20251990200020102020

Fractional works of Gilead Sciences (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Gilead Sciences (United Kingdom). Posts are plain text and can be reported.